ACTH Dependent Cushing’s Syndrome: A 72-Hour Trial of Octreotide will Identify Patients with Pituitary Dependent and Ectopic ACTH Overproduction
Omayma Elshafie & Nicholas Woodhouse · Journal of Advances in Medicine and Medical Research · 2020
Aims: To determine whether the use of an octreotide suppression test will reliably distinguish pituitary from ectopic ACTH overproduction. Somatostatin receptors are expressed in NETs, but are downgraded in the pituitary as the result of hypercortisolaemia. Octreotide should the...
Open access
Research Article
10.9734/jammr/2020/v32i1330554